Image

A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

Join a 52-week study for vitiligo treatment with Ritlecitinib capsules.

Recruiting
12 years and older
All
Phase 3

This study is examining a treatment called ritlecitinib for nonsegmental vitiligo, a skin condition causing white patches. The study lasts for 52 weeks (1 year) and tests the safety and effects of the treatment. It is a Phase 3 study, meaning it's in the final stage before potential approval. Participants must have vitiligo for at least 3 months, affecting 4%-60% of their body, including at least 0.5% of their face. They should have either active (new spots) or stable (no new spots) vitiligo. Participants must stop other vitiligo treatments during the study.

  • The study lasts for one year with regular check-ups.
  • Participants must be willing to stop other vitiligo treatments.
  • Eligible for ages 12 and up, with specific skin and health conditions.

Not everyone can join. Exclusions include certain skin diseases, infections, or psychiatric conditions. Safety is important, so previous severe allergies or certain health conditions are considered. Participants and their health will be carefully monitored to ensure safety throughout the study.

Study details
    Stable Nonsegmental Vitiligo
    Active Nonsegmental Vitiligo

NCT05583526

Pfizer

6 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.